You have 9 free searches left this month | for more free features.

Rhabdomyosarcoma of Mediastinum

Showing 1 - 25 of 156

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))

Terminated
  • Ewing Sarcoma
  • +10 more
  • Stereotactic Body Radiotherapy (SBRT)
  • Boston, Massachusetts
  • +2 more
Apr 5, 2021

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Not yet recruiting
  • Rhabdomyosarcoma
    • San Francisco, California
      Power Life Sciences
    Sep 1, 2023

    Saliva or Buccal Mucosa Samples From Embryonal or Alveolar

    Recruiting
    • Alveolar Rhabdomyosarcoma
    • Embryonal Rhabdomyosarcoma
    • Biospecimen Collection
    • +2 more
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Aug 8, 2022

    Rhabdomyosarcoma Trial in Sutton, Manchester (Irinotecan, Actinomycin D, Doxorubicin)

    Recruiting
    • Rhabdomyosarcoma
    • Camperdown, Australia
    • +89 more
    Jan 3, 2023

    FFPE Samples From Younger Patients With Rhabdomyosarcoma

    Completed
    • Alveolar Childhood Rhabdomyosarcoma
    • +2 more
      • Jinan, Shandong, China
        Jinan central hospital affiliated to Shandong First Medical Univ
      Sep 10, 2023

      Thyroid Disease Trial in Syracuse (SPECT)

      Enrolling by invitation
      • Thyroid Disease
      • SPECT
      • Syracuse, New York
        SUNY Upstate Medical University
      Aug 31, 2023

      Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United

      Recruiting
      • Embryonal Rhabdomyosarcoma
      • +2 more
      • Birmingham, Alabama
      • +47 more
      Aug 17, 2022

      Relapsed/Refractory Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Ewing Sarcoma Trial in United States (Eribulin

      Completed
      • Relapsed/Refractory Rhabdomyosarcoma
      • +2 more
      • Eribulin mesylate
      • Birmingham, Alabama
      • +40 more
      Mar 18, 2022

      Rhabdomyosarcoma, Child Trial (Realgar-Indigo Naturalis Formulation, Radiotherapy)

      Not yet recruiting
      • Rhabdomyosarcoma, Child
      • Realgar-Indigo Naturalis Formulation
      • Radiotherapy
      • (no location specified)
      Jan 31, 2023

      Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin

      Completed
      • Refractory or Recurrent Solid Tumors
      • +3 more
      • Eribulin mesilate
      • Irinotecan hydrochloride
      • Marseille, Bouches-du-Rhône, France
      • +38 more
      Jun 20, 2022

      Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)

      Not yet recruiting
      • Rhabdomyosarcoma, Child
      • (no location specified)
      Jul 13, 2022

      Mediastinum Disease Trial in Changsha (AI system)

      Recruiting
      • Mediastinum Disease
      • AI system
      • Changsha, Hunan, China
        The Third Xiangya Hospital of Central South University
      Mar 29, 2023

      Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

      Not yet recruiting
      • Rhabdomyosarcoma
      • Palo Alto, California
      • +2 more
      Aug 27, 2023

      Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,

      Suspended
      • Alveolar Rhabdomyosarcoma
      • +5 more
      • Birmingham, Alabama
      • +386 more
      Aug 18, 2022

      Cysts Trial in Maastricht

      Recruiting
      • Cysts
        • Maastricht, Limburg, Netherlands
          Maastricht UMC
        Apr 20, 2023

        Refractory and/or Relapsed Metastatic Solid Tumors Trial in United States (Cyclophosphamide, Fludarabine, low dose total body

        Recruiting
        • Refractory and/or Relapsed Metastatic Solid Tumors
        • Saint Petersburg, Florida
        • +4 more
        Oct 29, 2021

        Ventricular Arrhythmia, Ventricular Tachycardia, Ventricular Fibrillation Trial in Asunción (AtaCor EV-ICD Lead)

        Completed
        • Ventricular Arrhythmia
        • +2 more
        • AtaCor EV-ICD Lead
        • Asunción, Paraguay
          Sanatorio Italiano
        Jul 5, 2022

        Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

        Not yet recruiting
        • Neuroblastoma
        • (no location specified)
        Jun 17, 2022

        Thoracic Scanographic Characteristics of Hematologic Malignancy

        Recruiting
        • Mediastinal Diseases
        • analysis of thoracic scans
        • Toulouse, France
          Muriel Picard
        Jan 12, 2023

        Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)

        Recruiting
        • Rhabdomyosarcoma
        • Los Angeles, California
          UCLA / Jonsson Comprehensive Cancer Center
        May 13, 2022

        Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)

        Recruiting
        • Pediatric Sarcoma, Refractory
        • Pediatric Sarcoma, Relapsed
        • GEM/DOX + TGFBi expanded NK cells
        • Tampa, Florida
        • +1 more
        Jan 3, 2023

        Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma Trial in Worldwide

        Completed
        • Adult Rhabdomyosarcoma
        • +3 more
        • conventional surgery
        • +4 more
        • Birmingham, Alabama
        • +162 more
        Nov 17, 2021

        Recurrent and Refractory Solid Tumors Trial in Canada, United States (Lenvatinib, Everolimus)

        Completed
        • Recurrent and Refractory Solid Tumors
        • Birmingham, Alabama
        • +49 more
        Jan 27, 2023

        Soft Tissue Sarcoma Trial in Worldwide (trofosfamide, idarubicin, etoposide)

        Active, not recruiting
        • Soft Tissue Sarcoma
        • trofosfamide, idarubicin, etoposide
        • Graz, Austria
        • +73 more
        Nov 12, 2021